CN Stock MarketDetailed Quotes
600812 North China Pharmaceutical
- 5.56
- -0.09-1.59%
Market Closed Nov 15 15:00 CST
9.54BMarket Cap120.87P/E (TTM)
5.70High5.55Low109.65KlotVolume5.63Open5.65Pre Close61.78MTurnover0.64%Turnover Ratio1853.33P/E (Static)1.72BShares6.6552wk High1.78P/B9.54BFloat Cap3.8252wk Low6.22Limit Up1.72BShs Float20.14Historical High5.09Limit Down2.66%Amplitude0.62Historical Low0.01Dividend TTM5.63Avg Price57.61KlotAsk0.18%Div YieldTTM100Lot Size51.09KlotBid
About North China Pharmaceutical Company
The company's predecessor, the North China Pharmaceutical Factory, was a key construction project during China's “First Five-Year Plan”. Preparation began in June 1953, and was completed and put into operation in June 1958. It pioneered the history of large-scale antibiotic production in China, and made important contributions to the cause of human health, the development of the national pharmaceutical industry, and the shortage of medicines in China. The company was restructured in 1992 and listed on the Shanghai Stock Exchange in 1994. It is mainly engaged in R&D, production and sales of pharmaceutical products. The company's products cover the fields of chemical pharmaceuticals, modern biotechnological drugs, vitamins and health consumer products, biological pesticides and veterinary drugs, etc., covering more than 700 products such as anti-infective drugs, biotechnological drugs, cardiovascular and immunomodulators, vitamins and health consumer products. Corporate honors: 2017 - North China Pharmaceutical Group won the top ten export companies in China's Western Pharmaceutical Industry, 2016 - North China Pharmaceutical Group won the top ten pharmaceutical industry enterprises in Hebei Province, 2016 - North China Pharmaceutical Group won the top ten pharmaceutical industry enterprises in Hebei Province, 2014 - won the top 100 comprehensive strength industrial enterprises in China's chemical pharmaceutical industry, etc.
Company Profile
Short Name-A华北制药
Symbol-A600812
Company NameNORTH CHINA PHARMACEUTICAL COMPANY. LTD
Listing DateJan 14, 1994
Issue Price4.00
Shares Offered70.00M share(s)
FoundedDec 20, 1992
Listed ExchangeSH Stock Exchange
Legal Representativelixin wang
General Managerlixin wang
Secretaryzhiguang xiao
Accounting FirmLianda Certified Public Accountants (Special General Partnership)
Securities Representativejing yang
Legal CounselBeijing Deheng Law Firm
Employees3720
Phone0311-87173756
Office AddressNo. 388, Heping East Road, Shijiazhuang, Hebei
Zip Code050015
Registered AddressNo. 388, Heping East Road, Shijiazhuang, Hebei
Fax0311-86060942
Emailxiaozhiguang@ncpc.com
Websitehttp://www.ncpc.com
Business License130000000008365
BusinessPharmaceutical production and sales (operation according to the scope and validity period approved by the license); production and sale of Chinese medicine tablets (operation within the scope and validity period approved by the license); production and sale of pharmaceutical intermediates, plant extracts, and food additives; goods warehousing (except those prohibited or subject to approval by laws, regulations, or decisions of the State Council); general freight; import and export business of goods and technology, with the exception of goods and technology limited to the operation of companies or prohibited from import and export by the state; pharmaceutical and chemical technology transfer, technology development, technical consulting services; machinery and equipment cleaning, mechanical and electrical equipment installation, inspection and inspection; , packaging materials, cosmetics, office supplies, labor insurance products, daily department stores, clothing, construction materials, communication equipment, electronic products, plastic rubber products, auto parts, office furniture, lubricants, hardware, instrumentation, medicinal glass products, chemical reagents, mechanical equipment, electrical machinery and spare parts (except those requiring prior approval); sales of hygiene products; housing leasing; the following is limited to branch operations (involving licensed operations): pharmaceutical excipients (recombinant human leukin), tincture Agents, powders, hollow capsules, compounds, pill drops, oral Production of liquids and solutions; production and sale of recombinant human blood albumin (non-blood products, non-pharmaceuticals); veterinary drug sales; veterinary drug sales; wholesale of proprietary Chinese medicines, chemical raw materials and their preparations, antibiotic raw materials and their preparations, biochemical drugs, biological products, and class II psychotropic drug formulations; sales of sterilization products and medical devices; retail sales of family planning products (excluding pharmaceuticals and medical devices requiring approval), health products, pharmaceutical intermediates, plant extracts; pharmaceutical glass bottles, daily glass products, and industrial oxygen; pre-packaged food, chemical products, steel and its products, aluminum and its products, paper, non-ferrous metals , wholesale and retail of coke; R&D and technical consulting of traditional Chinese medicine products, traditional Chinese and Western medicine, biotechnology products, agricultural and veterinary drugs and comprehensive technology; production and technical consulting of general environmental cats (operated with the “Laboratory Animal Production License”) drug inspection services; R&D, processing, production and sales of prepackaged food, health food, and formula food for special medical purposes. Production and sale of raw materials for cosmetics and sanitary dressings; R&D, production, sales and technical consultation of biological products; (projects subject to approval according to law, business activities may only be carried out after approval by relevant departments).
Company Executives
- Name
- Position
- Salary
- lixin wang
- Chairman, directors, general manager, Member of the Nomination and Remuneration Assessment Committee, Chairman of the Strategy (Investment Decision) Committee
- 706.90K
- rentao song
- Directors
- --
- yao cao
- Directors, Audit Committee Members
- 200.40K
- yalou wang
- Directors, Member of the Nomination and Remuneration Assessment Committee
- 215.30K
- xiujun wang
- Directors
- --
- zhiguang xiao
- directors, Board Secretary, Chief Accountant, Head of Finance, Member of the Strategy (Investment Decision) Committee
- --
- yingzhe shi
- Independent directors, Audit Committee Member, Member of the Strategy (Investment Decision) Committee, Member of the Related Transactions Review Committee, Chairman of the Nomination and Remuneration Committee
- --
- demin zhou
- Independent directors, Member of the Strategy (Investment Decision) Committee, Member of the Nomination and Remuneration Assessment Committee, Audit Committee Members, Member of the Related Transactions Review Committee
- 71.40K
- zhenguo chai
- Independent directors, Audit Committee Members, Member of the Strategy (Investment Decision) Committee, Chairman of the Related Transactions Review Committee, Member of the Nomination and Remuneration Assessment Committee
- 71.40K
- guangcheng pan
- Independent directors, Member of the Nomination and Remuneration Assessment Committee, Member of the Strategy (Investment Decision) Committee, Audit Committee Members, Member of the Related Transactions Review Committee
- 71.40K
- jigang xie
- Independent directors, Member of the Nomination and Remuneration Assessment Committee, Chairman of the Audit Committee, Member of the Strategy (Investment Decision) Committee, Member of the Related Transactions Review Committee
- 71.40K
- jing yang
- Securities Affairs Representative
- --
- wei lv
- Chairman of the Supervisory Board, Auditors
- 355.50K
- lijun yang
- Auditors
- --
- wenzan gao
- Auditors
- --
- rongliang liu
- Deputy General Manager
- --
- min zhang
- Deputy General Manager
- --
- zhigang duan
- Deputy General Manager
- --
- tingde zhang
- General Counsel
- 766.90K
- suoqing zhang
- Employee Supervisors
- 326.30K
- fan li
- Employee Supervisors
- 322.30K
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data